文献速递传染病防控与疫情报告免疫规划卫生政策与健康促进

纽约州成年人新冠病例与住院率随疫苗接种状态的变化

New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status - New York, May 3-July 25, 2021.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2021-08-27

本研究由纽约州卫生部门链接全州免疫、实验室检测和住院数据库,估算2021年5月3日至7月25日成年人按疫苗接种状态的新冠确诊病例和住院率及疫苗有效性。结果显示,所有成年人年龄调整后针对新发病例的疫苗有效性从91.7%降至79.8%,而针对住院的疫苗有效性相对稳定在91.9%至95.3%之间。

要点

  • 针对新发病例的疫苗有效性从91.7%降至79.8%。
  • 针对住院的疫苗有效性稳定在91.9%至95.3%。
  • 建议采取以疫苗接种为中心的综合预防策略。

核心结论

  • 目前授权的新冠疫苗对住院具有高效性,但针对新发病例的有效性近月下降,与Delta变异株增多和口罩及物理距离建议放松同时发生。

研究设计与样本

  • 纽约州卫生部门链接全州免疫、实验室检测和住院数据库,估算2021年5月3日至7月25日成年人按疫苗接种状态的新冠确诊病例和住院率及疫苗有效性。

主要发现

  • 所有成年人年龄调整后针对新发病例的疫苗有效性从91.7%降至79.8%。
  • 同期年龄调整后针对住院的疫苗有效性相对稳定,范围为91.9%至95.3%。

临床怎么用

  • 为减少新冠病例和住院,应实施以疫苗接种为中心的综合方法,并辅以口罩和物理距离等其他预防策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Data from randomized clinical trials and real-world observational studies show that all three COVID-19 vaccines currently authorized for emergency use by the Food and Drug Administration* are safe and highly effective for preventing COVID-19-related serious illness, hospitalization, and death (1,2). Studies of vaccine effectiveness (VE) for preventing new infections and hospitalizations attributable to SARS-CoV-2, the virus that causes COVID-19), particularly as the B.1.617.2 (Delta) variant has become predominant, are limited in the United States (3). In this study, the New York State Department of Health linked statewide immunization, laboratory testing, and hospitalization databases for New York to estimate rates of new laboratory-confirmed COVID-19 cases and hospitalizations by vaccination status among adults, as well as corresponding VE for full vaccination in the population, across all three authorized vaccine products. During May 3-July 25, 2021, the overall age-adjusted VE against new COVID-19 cases for all adults declined from 91.7% to 79.8%. During the same period, the overall age-adjusted VE against hospitalization was relatively stable, ranging from 91.9% to 95.3%. Currently authorized vaccines have high effectiveness against COVID-19 hospitalization, but effectiveness against new cases appears to have declined in recent months, coinciding with the Delta variant's increase from <2% to >80% in the U.S. region that includes New York and relaxation of masking and physical distancing recommendations. To reduce new COVID-19 cases and hospitalizations, these findings support the implementation of a layered approach centered on vaccination, as well as other prevention strategies such as masking and physical distancing.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Rosenberg ES, Holtgrave DR, Dorabawila V, et al. New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status - New York, May 3-July 25, 2021. MMWR Morb Mortal Wkly Rep. 2021. PMID: 34437517. doi:10.15585/mmwr.mm7034e1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。